14 December 2021
Scientists have discovered a new potential treatment that has the ability to reverse antibiotic resistance in bacteria that cause conditions such as sepsis, pneumonia, and urinary tract infections.
30 November 2021
The Innovation Centre for Applied Sustainable Technologies (iCAST), a £17m collaboration aiming to translate sustainable chemical technology research into commercial products, recently launched in Swindon.
28 October 2021
Oxford Nanopore Technologies, a company which began as a spinout from the Department of Chemistry, has floated on the London Stock Exchange. It is the UK's biggest spinout IPO and the 5th biggest worldwide.
New research provides compelling evidence of the connection between AMR surgical-site infections and arthropods
30 September 2021
AMR could render many of the current mainstay and last-resort antibiotics useless, resulting in many more deaths from previously treatable infections. In 2019, a UN report estimated that drug-resistant microbes could lead to ten million deaths per year, and cost the world $100trn, by 2050.
17 September 2021
An international collaboration of 29 scientists around the world has focused on understanding how SARS-COV-2 makes its worker proteins at the molecular level in order to develop novel antiviral drugs that block their production.
8 September 2021
Five of the new Fellows are from MPLS Division. The Fellowships have been created by UKRI to help develop the next wave of world-class research and innovation leaders in academia and business.
18 August 2021
Professor Jonathan Doye from the Department of Chemistry writes about his research.
10 August 2021
Information about the most effective antibiotics to use in low and middle income countries (LMICs) for neonatal sepsis has been discovered uniquely combining epidemiological, genomic and pharmacodynamic data.
23 June 2021
A collaboration of biologists, chemists and physicists from the Universities of Oxford (UK) and Oldenburg (Germany) have been accumulating evidence that the magnetic sense in night migratory birds, such as the European robin, is based on a specific light‐sensitive protein in the eye.
18 May 2021
This is a new post, which will work in support of the priorities in the University Strategic Plan 2018-2023 and the Knowledge Exchange Strategy, around innovation and entrepreneurship.
14 May 2021
The University of Oxford joins a major new collaboration with academia and industry to use sustainable chemical technologies to accelerate the UK’s transition to net zero carbon emissions.
19 January 2021
Ineos, one of the world’s largest manufacturing companies, and the University of Oxford are launching a new world-leading institute to combat the growing global issue of antimicrobial resistance (AMR), which currently causes an estimated 1.5 million excess deaths each year.
9 December 2020
European Research Council grants worth more than €16.3 million have been awarded to University of Oxford researchers for a range of cutting-edge projects.
Major Chemistry Sponsor forms New Public/Private Partnership to help manufacture and distribute Oxford Covid-19 Vaccine
20 October 2020
Leading lights at Oxford University paved the way towards Oxford’s goal of global, rapid and equitable access to a safe, effective COVID-19 vaccine by facilitating an innovative public-private agreement for the manufacture and distribution of Oxford’s vaccine, ChAdOx1 nCoV-19.
16 October 2020
The Harrington Discovery Institute (HDI) in the US has announced five winners of its inaugural UK Rare Disease Scholar Award competition.